1.Valutazione economica dei costi associati al trattamento di pazienti in ossigenoterapia a lungo termine, con o senza monitoraggio telemetrico domiciliare

作　　者：Roberto Ravasio ;Roberto W. Dal Negro ;Carlo Lucioni

出　　处：Farmeconomia. Health economics and therapeutic pathways. 2005 ;6(4):349-352.doi:10.7175/fe.v6i4.846

出版社：SEEd

文章 ID：100545211

文章详细全文下载
2.Analisi di costo di pemetrexed vs docetaxel nel trattamento di seconda linea del carcinoma polmonare non a piccole cellule

作　　者：Roberto Ravasio

出　　处：Farmeconomia. Health economics and therapeutic pathways. 2005 ;6(2):119-126.doi:10.7175/fe.v6i2.827

出版社：SEEd

文章 ID：100545359

文章详细全文下载
3.The cost of a combination Anti-Retroviral Therapy (cART) optimization pathway as maintenance therapy in HIV-1 infected patients

作　　者：Roberto Ravasio ;Fabio Rigo ;Emanuela Lattuada 等

出　　处：Farmeconomia. Health economics and therapeutic pathways. 2017 ;18(1).doi:10.7175/fe.v18i1.1325

出版社：SEEd

文章 ID：206285151

文章详细全文下载
4.Economic implications in inflammatory bowel disease: results from a retrospective analysis in an Italian Centre

作　　者：Angela Variola ;Arianna Massella ;Andrea Geccherle 等

出　　处：Farmeconomia. Health economics and therapeutic pathways. 2017 ;18(1).doi:10.7175/fe.v18i1.1324

出版社：SEEd

文章 ID：206285153

文章详细全文下载
5.Budget impact analysis of dabigatran compared with rivaroxaban in the prevention of the thromboembolic risk in patients with non-valvular atrial fibrillation

作　　者：Maria Grazia Celeste ;Francesca De Marco ;Claudio Fresco 等

出　　处：Farmeconomia. Health economics and therapeutic pathways. 2017 ;18(1).doi:10.7175/fe.v18i1.1327

出版社：SEEd

文章 ID：206285155

文章详细全文下载
6.Cost-Consequence Analysis of Three Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

作　　者：Giovanni Gancitano ;Roberto Ravasio ;Matteo Dionisi 等

出　　处：Farmeconomia. Health economics and therapeutic pathways. 2018 ;19(1).doi:10.7175/fe.v19i1.1354

出版社：SEEd

文章 ID：224335614

文章详细
7.Clinical Impact of two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

作　　者：Giovanni Gancitano ;Roberto Ravasio ;Lorenzo Cattelino 等

出　　处：Farmeconomia. Health economics and therapeutic pathways. 2020 ;21(1).doi:10.7175/fe.v21i1.1450

出版社：SEEd

文章 ID：1030123333

文章详细
8.A Budget Impact Analysis of the VENTANA PD-L1 SP142 Immunohistochemistry Assay Versus the Dako PD-L1 IHC 22C3 Assay in Patients With Advanced or Metastatic Triple-Negative Breast Cancer Treated With Atezolizumab in Combination With Nab-Paclitaxel

作　　者：Cristian Scatena ;Roberto Ravasio ;Paola Raimondo 等

出　　处：Farmeconomia. Health economics and therapeutic pathways. 2021 ;22(1).doi:10.7175/fe.v22i1.1502

出版社：SEEd

文章 ID：1037051382

文章详细

	有本地全文	5篇
	有全文链接	3篇

	Roberto Ravasio	8篇
	Diego Cortinovis	2篇
	Giovanni Gancitano	2篇
	Andrea Geccherle	1篇
	Angela Variola	1篇

	Arianna Massella	1篇
	Carlo Lucioni	1篇
	Claudio Fresco	1篇
	Cristian Scatena	1篇
	Emanuela Lattuada	1篇
	Ercole Concia	1篇
	Fabio Rigo	1篇
	Francesca De Marco	1篇
	Giuseppe Musumeci	1篇
	Lorenzo Cattelino	1篇
	Maria Grazia Celeste	1篇
	Mario Giuliano	1篇
	Massimiliano Lanzafame	1篇
	Matteo Dionisi	1篇
	Paola Raimondo	1篇
	Paolo Bocus	1篇
	Paolo Di Procolo	1篇
	Roberto Tessari	1篇
	Roberto W. Dal Negro	1篇
	Teresa Zuppini	1篇

全文

出版年度

作者

来源期刊

学科主题

语种

国别/地区

检索条件:"( ( 高级检索(( ((AU:(("Roberto Ravasio")))) )) ) )"

	2021	1篇
	2020	1篇
	2018	1篇
	2017	3篇
	2005	2篇